Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Brain Neoplasms 3Supratentorial Neoplasms 2Oligodendroglioma 2Medulloblastoma 2Kidney Neoplasms 2Central Nervous System Neoplasms 2Astrocytoma 2Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Postoperative Complications 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Germ Cell and Embryonal 1Nasopharyngeal Carcinoma 1Intracranial Hypertension 1Hemorrhage 1Gliosarcoma 1Glioma 1Glioblastoma 1Familial ependymoma 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Cisplatin 104Radiotherapy, Intensity-Modulated 59Gemcitabine 53toripalimab 35Fluorouracil 30Docetaxel 30Capecitabine 28Radiotherapy 23Drug Therapy 20camrelizumab 19nimotuzumab 16nedaplatin 12Chemoradiotherapy 12sintilimab 11apatinib 11Induction Chemotherapy 11Immune Checkpoint Inhibitors 11spartalizumab 10endostar protein 8Paclitaxel 8Cetuximab 8tislelizumab 7pembrolizumab 7Endostatins 7Bevacizumab 7anlotinib 6Radiation 6Endoscopy 6fludarabine 5S 1 (combination) 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Nasopharyngeal Carcinoma × Mannitol × Clear all
NCT01865201 2013-12-12

Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Completed
154 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡